Related references
Note: Only part of the references are listed.PNA-based microRNA inhibitors elicit anti-inflammatory effects in microglia cells
Peter N. Brown et al.
CHEMICAL COMMUNICATIONS (2013)
MicroRNA biomarkers in glioblastoma
Simon Kjaer Hermansen et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Fluorescent Peptide-PNA Chimeras for Imaging Monoamine Oxidase A mRNA in Neuronal Cells
Dalip Sethi et al.
BIOCONJUGATE CHEMISTRY (2012)
Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells
Elisabetta Lambertini et al.
BMC CANCER (2012)
Cellular Uptakes, Biostabilities and Anti-miR-210 Activities of Chiral Arginine-PNAs in Leukaemic K562 Cells
Alex Manicardi et al.
CHEMBIOCHEM (2012)
P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3
Abdessamad Zerrouqi et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
MicroRNAs involved in the EGFR/PTEN/AKT pathway in gliomas
Yingyi Wang et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma
Chunzhi Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Sequence-Dependent Synergistic Inhibition of Human Glioma Cell Lines by Combined Temozolomide and miR-21 Inhibitor Gene Therapy
Xiaomin Qian et al.
MOLECULAR PHARMACEUTICS (2012)
Targeting microRNAs involved in human diseases: A novel approach for modification of gene expression and drug development
Roberto Gambari et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Insulin-like growth factor binding protein 7 exhibits tumor suppressive and vessel stabilization properties in U87MG and T98G glioblastoma cell lines
Ally Pen et al.
CANCER BIOLOGY & THERAPY (2011)
MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients
Radek Lakomy et al.
CANCER SCIENCE (2011)
Modulation of the Biological Activity of microRNA-210 with Peptide Nucleic Acids (PNAs)
Enrica Fabbri et al.
CHEMMEDCHEM (2011)
MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer
Maitri Y. Shah et al.
GENOME MEDICINE (2011)
Peptide nucleic acids (PNAs) antisense effect to bacterial growth and their application potentiality in biotechnology
Masashi Hatamoto et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2010)
Decoy oligodeoxyribonucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor kappa-B: Inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa
Roberto Gambari et al.
BIOCHEMICAL PHARMACOLOGY (2010)
An interview with Dr. Ian A.J. Lorimer on his highly cited paper published inCell Cycle
CELL CYCLE (2010)
HIPK2-A therapeutical target to be (re)activated for tumor suppression Role in p53 activation and HIF-1α inhibition
Lavinia Nardinocchi et al.
CELL CYCLE (2010)
Peptide Nucleic Acids (PNA) in Chemical Biology and Drug Discovery
Peter E. Nielsen
CHEMISTRY & BIODIVERSITY (2010)
Gene Targeting and Expression Modulation by Peptide Nucleic Acids (PNA)
Peter E. Nielsen
CURRENT PHARMACEUTICAL DESIGN (2010)
MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma
Chun-Zhi Zhang et al.
MOLECULAR CANCER (2010)
Efficient inhibition of miR-155 function in vivo by peptide nucleic acids
Martin M. Fabani et al.
NUCLEIC ACIDS RESEARCH (2010)
Prospects for antisense peptide nucleic acid (PNA) therapies for HIV
Virendra N. Pandey et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
A natural antisense transcript, BOKAS, regulates the pro-apoptotic activity of human Bok
Hong Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1
Ryo Ueda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Arginine-rich cell penetrating peptides: Design, structure-activity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides
R. Abes et al.
JOURNAL OF PEPTIDE SCIENCE (2008)
p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis
Monica Schiappacassi et al.
MOLECULAR CANCER THERAPEUTICS (2008)
miR-122 targeting with LNA/2′-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates
Martin M. Fabani et al.
RNA (2008)
Regulation of p27Kip1 by miRNA 221/222 in Glioblastoma
Jana K. Gillies et al.
CELL CYCLE (2007)
miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1*
Silvia Galardi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Regulation of the p27Kip1 tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation
Carlos le Sage et al.
EMBO JOURNAL (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
A novel function of OLIG2 to suppress human glial tumor cell growth via p27Kip1 transactivation
K Tabu et al.
JOURNAL OF CELL SCIENCE (2006)
Biological activity and delivery of peptide nucleic acids (PNA)-DNA chimeras for transcription factor decoy (TFD) pharmacotherapy
R Gambari
CURRENT MEDICINAL CHEMISTRY (2004)
Micrornas: Small RNAs with a big role in gene regulation
L He et al.
NATURE REVIEWS GENETICS (2004)
Enhanced recognition of cystic fibrosis W1282X DNA point mutation by chiral peptide nucleic acid probes by a surface plasmon resonance biosensor
R Corradini et al.
JOURNAL OF MOLECULAR RECOGNITION (2004)
Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites
M Borgatti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Arginine-rich molecular transporters for drug delivery: Role of backbone spacing in cellular uptake
JB Rothbard et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Peptide-nucleic acids (PNAs): A tool for the development of gene expression modifiers
R Gambari
CURRENT PHARMACEUTICAL DESIGN (2001)
Share Paper
